Skip to content
Study details
Enrolling now

1726-nm Laser for Acne Inversa (Hidradenitis Suppurativa)

Wynn Medical Center
NCT IDNCT07155239ClinicalTrials.gov data as of Apr 2026
Phase

Phase 1

Target enrollment

30

Study length

about 1.3 years

Ages

18–60

Locations

1 site in CA

What this study is about

This trial is testing whether a 1726-nm diode laser can safely reduce inflammatory HS lesions in Hurley stage I-II disease. Adults with bilateral affected areas will be randomized to receive active laser treatment or a sham procedure. Participants will have three treatment sessions over 8 weeks and follow-up through Week 24 while continuing their stable HS medications.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Use AviClear Lase Treatment
  • 2.Use Sham (No Treatment)

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Change in pain

Secondary: Change in depression scale